Todd Brinton

Clinical Focus

• Cardiovascular Disease
• Interventional Cardiology
• Cardiovascular Medicine

Professional Education

• Board Certification: Interventional Cardiology, American Board of Internal Medicine (2008)
• Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2007)
• Stanford University Hospital - Internal Medicine (2002) CA
• Stanford University (2006) CA
• Stanford University School of Medicine (2007) CA USA
• Board Certification: Internal Medicine, American Board of Internal Medicine (2003)
• Chicago Medical School (2000) IL

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: BioParadox, Impedence Cardiology Systems, Novartis
• Equity: BioParadox
• Service on Board of Directors: BioParadox, InfoGard Laboratories

Clinical Trials

• Safety and efficacy of using PROCHYMAL (a stem cell product) to treat acute heart attacks Recruiting

Publications

• Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. Fearon WF,  Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC.  J Am Coll Cardiol.  2008; 51 (5): 560-5
• Cutting balloon inflation for drug-eluting stent underexpansion due to unrecognized coronary arterial calcification. Wilson A,  Ardehali R, Brinton TJ, Yeung AC, Lee DP.  Cardiovasc Revasc Med.  2006 Jul-Sep; 7 (3): 185-8
• Successful removal of a paradoxical coronary embolus using an aspiration catheter. Wilson AM,  Ardehali R, Brinton TJ, Yeung AC, Vagelos R.  Nat Clin Pract Cardiovasc Med.  2006; 3 (11): 633-6